TABLE OF CONTENTS
1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET DEFINITION 11
1.3 OVERVIEW OF INDIA GENE SYNTHESIS MARKET 11
1.4 CURRENCY AND PRICING 13
1.5 LIMITATION 13
1.6 MARKETS COVERED 13
2 MARKET SEGMENTATION 15
2.1 MARKETS COVERED 15
2.2 GEOGRAPHIC SCOPE 16
2.3 YEARS CONSIDERED FOR THE STUDY 16
2.4 CURRENCY AND PRICING 16
2.5 RESEARCH METHODOLOGY 17
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 20
2.7 MULTIVARIATE MODELLING 21
2.8 COMPONENT SEGMENT LIFELINE CURVE 21
2.9 DBMR MARKET POSITION GRID 22
2.10 MARKET APPLICATION COVERAGE GRID 24
2.11 THE CATEGORY VS TIME GRID 25
2.12 SECONDARY SOURCES 26
2.13 ASSUMPTIONS 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 30
4.1 PESTEL 31
4.2 PORTER'S FIVE FORCES MODEL 32
4.3 MARKET POTENTIAL 33
4.4 PRICING ANALYSIS 35
5 INDIA GENE SYNTHESIS MARKET: REGULATIONS 37
6 MARKET OVERVIEW 38
6.1 DRIVERS 40
6.1.1 INCREASED PREVALENCE OF CHRONIC INFECTIOUS DISEASES 40
6.1.2 RISING ADOPTION OF GENE THERAPY 40
6.1.3 EXPANSION OF SYNTHETIC BIOLOGY 41
6.1.4 RISING INTEREST IN GENE SYNTHESIS IN THE FIELD OF MOLECULAR BIOLOGY 42
6.2 RESTRAINTS 42
6.2.1 LACK OF TRAINED PROFESSIONALS 42
6.2.2 ETHICAL ISSUES 43
6.3 OPPORTUNITIES 43
6.3.1 RISE IN HEALTHCARE EXPENDITURE 43
6.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS 44
6.3.3 RISING DEMAND FOR CUSTOMIZED/PERSONALIZED MEDICATIONS 44
6.4 CHALLENGES 45
6.4.1 TECHNICAL LIMITATIONS ACROSS THE PRODUCTION PROCESS 45
6.4.2 REGULATORY FRAMEWORK 45
7 INDIA GENE SYNTHESIS MARKET, BY COMPONENT 46
7.1 OVERVIEW 47
7.2 SOFTWARE & SERVICES 50
7.3 CONSUMABLES 50
7.3.1 REAGENTS 50
7.3.2 ASSAYS 50
7.3.3 PROBES & DYES 50
7.3.4 OTHERS 50
7.4 SYNTHESIZER 51
7.4.1 COLUMN-BASED SYNTHESIZERS 51
7.4.2 MICROARRAY-BASED SYNTHESIZERS 51
8 INDIA GENE SYNTHESIS MARKET, BY GENE TYPE 52
8.1 OVERVIEW 53
8.2 STANDARD GENE 56
8.3 COMPLEX GENE 56
8.4 EXPRESS GENE 56
8.5 OTHERS 56
9 INDIA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE 57
9.1 OVERVIEW 58
9.2 CUSTOM GENE SYNTHESIS 61
9.2.1 STANDARD GENE 61
9.2.2 COMPLEX GENE 61
9.2.3 EXPRESS GENE 61
9.2.4 OTHERS 61
9.3 GENE LIBRARY SYNTHESIS 62
9.3.1 STANDARD GENE 62
9.3.2 COMPLEX GENE 62
9.3.3 EXPRESS GENE 62
9.3.4 OTHERS 62
10 INDIA GENE SYNTHESIS MARKET, BY APPLICATION 63
10.1 OVERVIEW 64
10.2 SYNTHETIC BIOLOGY 67
10.2.1 CUSTOM GENE SYNTHESIS 67
10.2.2 GENE LIBRARY SYNTHESIS 67
10.3 GENETIC ENGINEERING 67
10.3.1 CUSTOM GENE SYNTHESIS 68
10.3.2 GENE LIBRARY SYNTHESIS 68
10.4 THERAPEUTIC ANTIBODIES 68
10.4.1 CUSTOM GENE SYNTHESIS 68
10.4.2 GENE LIBRARY SYNTHESIS 68
10.5 VACCINE DESIGN 69
10.5.1 CUSTOM GENE SYNTHESIS 69
10.5.2 GENE LIBRARY SYNTHESIS 69
10.6 OTHERS 69
11 INDIA GENE SYNTHESIS MARKET, BY METHOD 70
11.1 OVERVIEW 71
11.2 PCR-BASED ENZYME SYNTHESIS 74
11.3 CHIP-BASED DNA SYNTHESIS 74
11.4 SOLID BASED SYNTHESIS 74
12 INDIA GENE SYNTHESIS MARKET, BY END USER 75
12.1 OVERVIEW 76
12.2 ACADEMIC & RESEARCH INSTITUTE 79
12.3 BIOTECH & PHARMACEUTICAL COMPANIES 79
12.4 CONTRACT RESEARCH ORGANIZATIONS (CROS) 79
12.5 DIAGNOSTIC LABORATORIES 79
12.6 AGRICULTURE 79
12.7 FOOD 79
12.8 OTHERS 79
13 INDIA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL 80
13.1 OVERVIEW 81
13.2 DIRECT TENDER 84
13.3 ONLINE DISTRIBUTION 84
13.4 THIRD PARTY DISTRIBUTORS 84
14 INDIA GENE SYNTHESIS MARKET: COMPANY LANDSCAPE 85
14.1 COMPANY SHARE ANALYSIS: INDIA 85
15 SWOT ANALYSIS 86
16 COMPANY PROFILE 87
16.1 THERMO FISHER SCIENTIFIC INC. 87
16.1.1 COMPANY SNAPSHOT 87
16.1.2 REVENUE ANALYSIS 87
16.1.3 PRODUCT PORTFOLIO 88
16.1.4 RECENT DEVELOPMENT 88
16.2 EUROFINS SCIENTIFIC 89
16.2.1 COMPANY SNAPSHOT 89
16.2.2 REVENUE ANALYSIS 89
16.2.3 SERVICE PORTFOLIO 90
16.2.4 RECENT DEVELOPMENT 90
16.3 MERCK KGAA 91
16.3.1 COMPANY SNAPSHOT 91
16.3.2 REVENUE ANALYSIS 91
16.3.3 PRODUCT PORTFOLIO 92
16.3.4 RECENT DEVELOPMENT 92
16.4 KANEKA EUROGENTEC S.A. 93
16.4.1 COMPANY SNAPSHOT 93
16.4.2 REVENUE ANALYSIS 93
16.4.3 PRODUCT PORTFOLIO 94
16.4.4 RECENT DEVELOPMENTS 94
16.5 BOSTER BIOLOGICAL TECHNOLOGY 95
16.5.1 COMPANY SNAPSHOT 95
16.5.2 SERVICE PORTFOLIO 95
16.5.3 RECENT DEVELOPMENT 95
16.6 GCC BIOTECH (INDIA) PVT. LTD. 96
16.6.1 COMPANY SNAPSHOT 96
16.6.2 PRODUCT PORTFOLIO 96
16.6.3 RECENT DEVELOPMENT 96
16.7 GENSCRIPT 97
16.7.1 COMPANY SNAPSHOT 97
16.7.2 REVENUE ANALYSIS 97
16.7.3 PRODUCT PORTFOLIO 98
16.7.4 RECENT DEVELOPMENTS 98
16.8 ORIGENE TECHNOLOGIES, INC 99
16.8.1 COMPANY SNAPSHOT 99
16.8.2 PRODUCT PORTFOLIO 99
16.8.3 RECENT DEVELOPMENTS 99
16.9 SYNBIO TECHNOLOGIES 100
16.9.1 COMPANY SNAPSHOT 100
16.9.2 PRODUCT PORTFOLIO 100
16.9.3 RECENT DEVELOPMENTS 100
16.10 TWIST BIOSCIENCE 101
16.10.1 COMPANY SNAPSHOT 101
16.10.2 REVENUE ANALYSIS 101
16.10.3 PRODUCT PORTFOLIO 102
16.10.4 RECENT DEVELOPMENTS 102
17 QUESTIONNAIRE 103
18 RELATED REPORTS 107

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.